It is considered a safe treatment, as there are no known side effects or interactions with other drugs
Much of what we know about the connection between GLP-1 RAs and fertility comes from data involving individuals with PMOS
In this report, we cover views of: The use of weight-loss drugs The impact of weight-loss drugs on obesity in America The factors that impact a persons weight, including the role of willpower Views of weight-loss drugs About three-quarters of Americans say they have heard a lot or a little about Ozempic, Wegovy and other similar drugs that are being used for weight loss
Phase 3 clinical trials demonstrated a significant reduction in visceral fat without major metabolic side effects (Falutz et al., J Clin Endocrinol Metab 2010)
This research peptide represents a novel approach to metabolic regulation, offering unprecedented insights into multi-pathway targeting for comprehensive metabolic research applications and obesity studies
Learn more about our expert-led weight loss programmes